The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Etiology and Pathogenesis in Primary Sclerosing Cholangitis
Abstract
The etiology and pathogenesis of the inflammatory and fibrotic bile duct lesions characteristic of primary sclerosing cholangitis (PSC) is unknown, but several lines of evidence support the contention that genetic and immunologic factors are involved. There is an association with human leukocyte antigens (HLA) with an increased frequency of DR3, DR6, and DR2 positive haplotypes. DRB3*0101(DR52a) is the most strongly associated allele in some studies, but the HLA gene conferring the primary HLA associated susceptibility to PSC remains to be established. There is an aberrant expression of HLA class II antigens (DR and DP) on bile duct epithelial cells, with the potential to present antigens to the surrounding T-lymphocytes. A defective suppressor T-cell function has been suggested in some studies. The patients may have elevated levels of circulating immune complexes, immunoglobulins, and non-organ-specific autoantibodies. Antibodies to perinuclear antigens (pANCA) are present in about 80% of cases. Increased metabolism of complement C3, reduced clearance of immune complexes, and increased concentration of biliary immune complexes have been found. The strong association between PSC and ulcerative colitis (UC) has not been explained. The detection of circulating IgG antibodies against a specific epitope shared by epithelial cells in the bile ducts and colon in about two-thirds of PSC patients may be of importance. Portal bacteremia secondary to a diseased bowel may possibly contr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Portal bacteraemia, reported in patients with active colitis, may be another important contributing factor.225,226”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [226]
Citations
Cites
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
Bottazzo, G., Hanafusa, T., Pujol-Borrell, R., & Feldmann, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90629-3 · Cited by 1,256
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Fibrogenic cytokines: the role of immune mediators in the development of scar tissue
Kovacs, E. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90107-5 · Cited by 590
Campbell, R. D., & Trowsdale, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90234-c · Cited by 579
Clinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Research works printed but not linked: 16
- Holubitsky I B, 1964, Can J Surg, 7, 277
- Wiesner R H, 1989, Hepa-tology, 10, 430
- Quigley E MM, 1987, Gastroenterology, 92, 1585
- Shepherd H A, 1983, Q J Med, 208, 503
- Broomé U, 1993, Hepatology, 18, 298
- Boberg K M, 1993, J Hepatol, 18, S97
- Ayres R CS, 1991, Hepatology, 14, 97A
- Boberg K M, Scand J Gastroenterol
- Alberti-Flor J J, 1986, Am J Gastroenterol, 81, 325
- Snook J A, 1989, Clin Exp Immunol, 76, 30
- Mulder A HL, 1993, Hepatology, 17, 411, 10.1002/hep.1840170310 · doi:10.1002/hep.1840170310 · Paper page
- Vidrich A, 1993, Gastroenterology, 104, A1015
- Miller L C, 1992, Am J Gastroenterol, 87, 465
- Fox E S, 1990, Lab Invest, 63, 733
- Fukuzumi S, 1990, Eur J Surg Oncol, 16, 251
- Terblanche J, 1983, Surgery, 94, 52
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Boberg, K. M., Fausa, O., Haaland, T., Holter, E., Mellbye, O. J., Spurkland, A., & Schrumpf, E. (1996) · Hepatology · doi:10.1002/hep.510230612 · Cited by 205
Self-citationIncreased frequency of autoimmune diseases in patients with primary sclerosing cholangitis
Saarinen, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02085-2 · Cited by 195
“The etiology of PSC remains unknown but several immunological disturbances frequently seen in these patients strongly suggest that the immune system is involved in the etiopathogenetical mechanism (4).”
BackgroundHLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
Spurkland, A., Saarinen, S., Boberg, K. M., Mitchell, S., Broome, U., Caballeria, L., Ciusani, E., Chapman, R., Ercilla, G., Fausa, O., et al. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530502.x · Cited by 171
Self-citationShetty, K., Rybicki, L. A., & Carey, W. D. (1997) · Hepatology · doi:10.1002/hep.510250501 · Cited by 129
Metadata
- Authors
- Boberg, K. M., Lundin, K. E. A., & Schrumpf, E.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 1994-01
- Volume
- 29
- Issue
- sup204
- Pages
- 47-58
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W1999569800
- Cited by
- 53
- References
- 129
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2018: 2 · 2016: 3 · 2015: 1 · 2013: 1
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, etiology, pathogenesis, HLA-DR3, immune complexes, ulcerative colitis, viral infection, bile duct fibrosis
- MeSH terms
- Antibody Formation, HLA Antigens, Humans, Immunity, Cellular, Cholangitis, Sclerosing, Autoimmunity, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Etiology and Pathogenesis in Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.3109/00365529409103625
- The paper
- Boberg, K. M., Lundin, K. E. A., & Schrumpf, E. (1994). Etiology and Pathogenesis in Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365529409103625
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.